The tumor suppressor CYLD regulates the p53 DNA damage response

dc.contributor.author
Fernández-Majada, Vanesa
dc.contributor.author
Welz, Patrick-Simon
dc.contributor.author
Ermolaeva, Maria
dc.contributor.author
Schell, Michael
dc.contributor.author
Adam, Alexander
dc.contributor.author
Dietlein, Felix
dc.contributor.author
Komander, David
dc.contributor.author
Büttner, Reinhard
dc.contributor.author
Thomas, Roman K.
dc.contributor.author
Schumacher, Björn
dc.contributor.author
Pasparakis, Manolis
dc.date.issued
2022-11-09T17:37:07Z
dc.date.issued
2022-11-09T17:37:07Z
dc.date.issued
2016
dc.date.issued
2022-11-09T17:37:07Z
dc.identifier
2041-1723
dc.identifier
https://hdl.handle.net/2445/190635
dc.identifier
700997
dc.identifier
27561390
dc.description.abstract
The tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-κB, MAP kinase and Wnt signalling. However, the tumour suppressing mechanisms of CYLD remain poorly understood. Here we show that loss of CYLD catalytic activity causes impaired DNA damage-induced p53 stabilization and activation in epithelial cells and sensitizes mice to chemical carcinogen-induced intestinal and skin tumorigenesis. Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress. Ubiquitin chain-restriction analysis provides evidence that CYLD removes K48 ubiquitin chains from p53 indirectly by cleaving K63 linkages, suggesting that p53 is decorated with complex K48/K63 chains. Moreover, CYLD deficiency also diminishes CEP-1/p53-dependent DNA damage-induced germ cell apoptosis in the nematode Caenorhabditis elegans. Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD.
dc.format
14 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/ncomms12508
dc.relation
Nature Communications, 2016, vol. 7
dc.relation
https://doi.org/10.1038/ncomms12508
dc.relation
info:eu-repo/grantAgreement/EC/FP7/223151/EU//INFLA-CARE
dc.relation
info:eu-repo/grantAgreement/EC/FP7/260383/EU//GENSTAGE
dc.relation
info:eu-repo/grantAgreement/EC/FP7/309756/EU//UBSPECIFIC
dc.relation
info:eu-repo/grantAgreement/EC/FP7/316354/EU//CODEAGE
dc.relation
info:eu-repo/grantAgreement/EC/FP7/316390/EU//ADDRESS
dc.relation
info:eu-repo/grantAgreement/EC/FP7/316964/EU//MARRIAGE
dc.relation
info:eu-repo/grantAgreement/EC/FP7/323040/EU//EPINFLAM
dc.rights
cc-by (c) Fernández-Majada, Vanesa et al., 2016
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Apoptosi
dc.subject
Carcinogènesi
dc.subject
Experimentació animal
dc.subject
Apoptosis
dc.subject
Carcinogenesis
dc.subject
Animal experimentation
dc.title
The tumor suppressor CYLD regulates the p53 DNA damage response
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)